Lenglet, Aurelie
Jaisson, Stéphane
Gillery, Philippe
El Balkhi, Souleiman
Liabeuf, Sophie
Massy, Ziad A.
Article History
Received: 1 December 2022
Accepted: 18 July 2023
First Online: 2 August 2023
Declarations
:
: Z. Massy reports grants and fees from Amgen, grants and fees from Sanofi-Genzyme, grants from the French government, grants from MSD, grants from GSK, grants from Lilly, grants from FMC, grants and fees from Baxter, grants from Outsuka, fees from Daichi, and fees from Astellas, all outside the submitted work. The other authors have nothing to disclose.
: The study protocol was approved by a local investigational review board (CPP Nord Ouest II, Amiens, France; reference: 2008-004673-17) and implemented in accordance with the ethical principles of the Declaration of Helsinki (ClinicalTrials.gov registration number: NCT01011699).
: All participants gave their written consent to participation in the study.